{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:52:59Z","timestamp":1790434379496,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","award":["U2C ES026553"],"award-info":[{"award-number":["U2C ES026553"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008269","name":"Michigan Institute for Clinical and Health Research","doi-asserted-by":"publisher","award":["UL1TR000433"],"award-info":[{"award-number":["UL1TR000433"]}],"id":[{"id":"10.13039\/100008269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00216-019-01719-z","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T06:40:23Z","timestamp":1554187223000},"page":"6297-6308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Application of differential mobility-mass spectrometry for untargeted human plasma metabolomic analysis"],"prefix":"10.1007","volume":"411","author":[{"given":"Stefanie","family":"Wernisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramaniam","family":"Pennathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"key":"1719_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17:448.","journal-title":"Nat Med"},{"issue":"10","key":"1719_CR2","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1172\/JCI64801","volume":"123","author":"TJ Wang","year":"2013","unstructured":"Wang TJ, Ngo D, Psychogios N, Dejam A, Larson MG, Vasan RS, et al. 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest. 2013;123(10):4309\u201317.","journal-title":"J Clin Invest"},{"issue":"1","key":"1719_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/msb.2012.43","volume":"8","author":"R Wang-Sattler","year":"2012","unstructured":"Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol. 2012;8(1):615.","journal-title":"Mol Syst Biol"},{"key":"1719_CR4","doi-asserted-by":"crossref","unstructured":"Sas KM, Kayampilly P, Byun J, Nair V, Hinder LM, Hur J, et al. Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. JCI Insight. 2016;1(15).","DOI":"10.1172\/jci.insight.86976"},{"issue":"5","key":"1719_CR5","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576\u201385.","journal-title":"Nat Med"},{"issue":"17","key":"1719_CR6","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WH Tang","year":"2013","unstructured":"Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. New Engl J Med. 2013;368(17):1575\u201384.","journal-title":"New Engl J Med"},{"key":"1719_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57.","journal-title":"Nature"},{"issue":"24","key":"1719_CR8","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1158\/0008-5472.CAN-11-1154","volume":"71","author":"N Putluri","year":"2011","unstructured":"Putluri N, Shojaie A, Vasu VT, Vareed SK, Nalluri S, Putluri V, et al. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression. Cancer Res. 2011;71(24):7376\u201386.","journal-title":"Cancer Res"},{"issue":"1","key":"1719_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1681\/ASN.2017030350","volume":"29","author":"F Afshinnia","year":"2018","unstructured":"Afshinnia F, Rajendiran TM, Soni T, Byun J, Wernisch S, Sas KM, et al. Impaired \u03b2-oxidation and altered complex lipid fatty acid partitioning with advancing CKD. J Am Soc Nephrol. 2018;29(1):295\u2013306.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1719_CR10","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/ki.2013.497","volume":"85","author":"MA Niewczas","year":"2014","unstructured":"Niewczas MA, Sirich TL, Mathew AV, Skupien J, Mohney RP, Warram JH, et al. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney Int. 2014;85(5):1214\u201324.","journal-title":"Kidney Int"},{"issue":"4","key":"1719_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ekir.2016.08.007","volume":"1","author":"F Afshinnia","year":"2016","unstructured":"Afshinnia F, Rajendiran TM, Karnovsky A, Soni T, Wang X, Xie D, et al. Lipidomic signature of progression of chronic kidney disease in the chronic renal insufficiency cohort. Kidney Int Reports. 2016;1(4):256\u201368.","journal-title":"Kidney Int Reports"},{"key":"1719_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrneph.2017.30","volume":"13","author":"B Hocher","year":"2017","unstructured":"Hocher B, Adamski J. Metabolomics for clinical use and research in chronic kidney disease. Nat Rev Nephrol. 2017;13:269.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"1719_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4155\/bio.15.14","volume":"7","author":"JL Campbell","year":"2015","unstructured":"Campbell JL, Blanc JYL, Kibbey RG. Differential mobility spectrometry: a valuable technology for analyzing challenging biological samples. Bioanalysis. 2015;7(7):853\u20136.","journal-title":"Bioanalysis"},{"key":"1719_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.aca.2017.08.023","volume":"991","author":"C Liu","year":"2017","unstructured":"Liu C, G\u00f3mez-R\u00edos GA, Schneider BB, Le Blanc JCY, Reyes-Garc\u00e9s N, Arnold DW, et al. Fast quantitation of opioid isomers in human plasma by differential mobility spectrometry\/mass spectrometry via SPME\/open-port probe sampling interface. Anal Chim Acta. 2017;991:89\u201394.","journal-title":"Anal Chim Acta"},{"issue":"34","key":"1719_CR15","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.1039\/C7AY00892A","volume":"9","author":"I Ayodeji","year":"2017","unstructured":"Ayodeji I, Vazquez T, Bailey R, Evans-Nguyen T. Rapid pre-filtering of amphetamine and derivatives by direct analysis in real time (DART)-differential mobility spectrometry (DMS). Anal Methods. 2017;9(34):5044\u201351.","journal-title":"Anal Methods"},{"key":"1719_CR16","doi-asserted-by":"crossref","unstructured":"Chen Z, Coy SL, Pannkuk EL, Laiakis EC, Fornace AJ, Vouros P. Differential mobility spectrometry-mass spectrometry (DMS-MS) in radiation biodosimetry: rapid and high-throughput quantitation of multiple radiation biomarkers in nonhuman primate urine. J Am Soc Mass Spectr. 2018.","DOI":"10.1007\/s13361-018-1977-z"},{"issue":"12","key":"1719_CR17","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1007\/s00216-018-0978-x","volume":"410","author":"S Wernisch","year":"2018","unstructured":"Wernisch S, Afshinnia F, Rajendiran T, Pennathur S. Probing the application range and selectivity of a differential mobility spectrometry\u2013mass spectrometry platform for metabolomics. Anal Bioanal Chem. 2018;410(12):2865\u201377.","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"1719_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jms.1383","volume":"43","author":"AB Kanu","year":"2008","unstructured":"Kanu AB, Dwivedi P, Tam M, Matz L, Hill HH. Ion mobility\u2013mass spectrometry. J Mass Spectrom. 2008;43(1):1\u201322.","journal-title":"J Mass Spectrom"},{"key":"1719_CR19","unstructured":"Wernisch S, Afshinnia F, Rajendiran TM, Pennathur S. Differential mobility \u2013 mass spectrometry metabolomics platform for biomarker discovery in chronic kidney disease. Annual Meeting of the American Society for Mass Spectrometry; 2017; Indianapolis, IN."},{"issue":"3","key":"1719_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1053\/j.ajkd.2010.03.026","volume":"56","author":"LA Stevens","year":"2010","unstructured":"Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, et al. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL\/min\/1.73 m2. Am J Kidney Dis. 2010;56(3):486\u201395.","journal-title":"Am J Kidney Dis"},{"issue":"W1","key":"1719_CR21","doi-asserted-by":"publisher","first-page":"W251","DOI":"10.1093\/nar\/gkv380","volume":"43","author":"J Xia","year":"2015","unstructured":"Xia J, Sinelnikov IV, Han B, Wishart DS. MetaboAnalyst 3.0\u2014making metabolomics more meaningful. Nucleic Acids Res. 2015;43(W1):W251\u2013W7.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1719_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/cem.2609","volume":"28","author":"RG Brereton","year":"2014","unstructured":"Brereton RG, Lloyd GR. Partial least squares discriminant analysis: taking the magic away. J Chemom. 2014;28(4):213\u201325.","journal-title":"J Chemom"},{"key":"1719_CR23","doi-asserted-by":"crossref","unstructured":"Anwar A, Psutka J, Walker SWC, Dieckmann T, Janizewski JS, Larry Campbell J, et al. Separating and probing tautomers of protonated nucleobases using differential mobility spectrometry. Int J Mass Spectrom. 2017.","DOI":"10.1016\/j.ijms.2017.08.008"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-019-01719-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-019-01719-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-019-01719-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T09:34:29Z","timestamp":1589621669000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-019-01719-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":23,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1719"],"URL":"https:\/\/doi.org\/10.1007\/s00216-019-01719-z","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,2]]},"assertion":[{"value":"3 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All human studies were approved by the Institutional Review Board (IRB) for the University of Michigan and the CPROBE ancillary studies committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}